Fran McCaffery didn’t get to see the end of the Big Ten Tournament game for his Iowa team. He was ejected from the contest ...

During the third quarter of fiscal year 2025 (“Q3 FY2025”) and to date in 2025, HeartSciences has seen material progress towards FDA submissions of our products and there have been significant ...

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.

Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has been granted patent for its drug candidate AC01 as an inotropic ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to treating cardiometabolic diseases driven ...

Even modern cancer treatments appear risky for the heart, especially if the radiation dose to the LAD is high.

Medera announced that patient dosing has been completed in its MUSIC-HFrEF Phase 1/2a clinical trial of the gene therapy candidate SRD-001 in ...

Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently ...

An association between stress and cryptogenic ischemic stroke was observed in young women, but not young men, in a ...

More frequent placement of central venous catheter seen for patients with heart failure with reduced ejection fraction ...

In this deep dive, BioSpace explores the diverse therapeutic modalities now in development, as well as the opportunities and ...